{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:46:04Z","timestamp":1791233164881,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008741","name":"European League Against Rheumatism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008741","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.semarthrit.2019.07.007","type":"journal-article","created":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T01:43:26Z","timestamp":1563587006000},"page":"140-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Sex hormones and sex hormone-targeting therapies in systemic sclerosis: A systematic literature review"],"prefix":"10.1016","volume":"50","author":[{"given":"Jacopo","family":"Ciaffi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina M.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan W.","family":"Schoones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom W.J.","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeska K.","family":"de Vries-Bouwstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.semarthrit.2019.07.007_bib0001","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.07.007_bib0002","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00281-015-0507-3","article-title":"Environmental risk factors of systemic sclerosis","volume":"37","author":"Marie","year":"2015","journal-title":"Semin Immunopathol"},{"issue":"Suppl 106(4)","key":"10.1016\/j.semarthrit.2019.07.007_bib0003","first-page":"89","article-title":"Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a spanish systemic sclerosis cohort and literature review","volume":"35","author":"Freire","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.07.007_bib0004","first-page":"177","article-title":"Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes","volume":"1","author":"Peoples","year":"2016","journal-title":"J Scleroderma Relat Disord"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.07.007_bib0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/rheumatology\/kew047","article-title":"Digital ulcers in systemic sclerosis","volume":"56","author":"Hughes","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.07.007_bib0006","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12016-013-8392-9","article-title":"The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance","volume":"47","author":"D'Amico","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"issue":"11","key":"10.1016\/j.semarthrit.2019.07.007_bib0007","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s40265-014-0259-8","article-title":"Dehydroepiandrosterone (DHEA): hypes and hopes","volume":"74","author":"Rutkowski","year":"2014","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.semarthrit.2019.07.007_bib0008","first-page":"347","article-title":"Cyclophosphamide-induced gonadal toxicity: a treatment dilemma in patients with lupus nephritis?","volume":"62","author":"Wetzels","year":"2004","journal-title":"Neth J Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.07.007_bib0009","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/art.40057","article-title":"Effect of corticosteroids and cyclophosphamide on sex hormone profiles in male patients with systemic lupus erythematosus or systemic sclerosis","volume":"69","author":"Arnaud","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.07.007_bib0010","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/jc.2015-3640","article-title":"Genetics of common endocrine disease: the present and the future","volume":"101","author":"Goodarzi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.semarthrit.2019.07.007_bib0011","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.tem.2012.03.006","article-title":"The endocrine effects of nicotine and cigarette smoke","volume":"23","author":"Tweed","year":"2012","journal-title":"Trends Endocrinol. Metab"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.07.007_bib0012","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/01.ALC.0000125356.70824.81","article-title":"Effect of moderate alcohol consumption on plasma dehydroepiandrosterone sulfate, testosterone, and estradiol levels in middle-aged men and postmenopausal women: a diet-controlled intervention study","volume":"28","author":"Sierksma","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.07.007_bib0013","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12263-017-0555-5","article-title":"Food components and contaminants as (anti)androgenic molecules","volume":"12","author":"Marcoccia","year":"2017","journal-title":"Genes Nutr"},{"issue":"10","key":"10.1016\/j.semarthrit.2019.07.007_bib0014","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/j.fct.2011.07.039","article-title":"Estrogens in the daily diet: in vitro analysis indicates that estrogenic activity is omnipresent in foodstuff and infant formula","volume":"49","author":"Behr","year":"2011","journal-title":"Food Chem toxicol Int J Published Br Ind Biol Res Assoc"},{"key":"10.1016\/j.semarthrit.2019.07.007_bib0015","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3389\/fimmu.2018.01332","article-title":"Glucocorticoids, sex hormones, and immunity","volume":"9","author":"Bereshchenko","year":"2018","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.07.007_bib0016","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1568-9972(02)00064-2","article-title":"Sex hormones and rheumatoid arthritis","volume":"1","author":"Cutolo","year":"2002","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.07.007_bib0017","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/0961203308090026","article-title":"Sex hormones and systemic lupus erythematosus","volume":"17","author":"Petri","year":"2008","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.07.007_bib0018","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the american rheumatism association diagnostic and therapeutic criteria committee","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.07.007_bib0019","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2019.07.007_bib0020","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an american college of rheumatology\/European league against rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.07.007_bib0021","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6947-7-16","article-title":"Utilization of the PICO framework to improve searching pubmed for clinical questions","volume":"7","author":"Schardt","year":"2007","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.semarthrit.2019.07.007_bib0022","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2019.07.007_bib0023","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle\u2013Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. 2019 [Available from:http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp (Accessed 26 April 2019)"},{"key":"10.1016\/j.semarthrit.2019.07.007_bib0024","unstructured":"Johanna-Briggs Institute. Critical appraisal tools 2017 [Available from: http:\/\/joannabriggs.org\/research\/critical-appraisal-tools.html (Accessed 26 April 2019)"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.07.007_bib0025","doi-asserted-by":"crossref","first-page":"R10","DOI":"10.1186\/ar4140","article-title":"Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis","volume":"15","author":"Aida-Yasuoka","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.07.007_bib0026","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/03009749209099231","article-title":"Long-term evaluation of penicillamine or cyclofenil in systemic-sclerosis \u2013 results from a 2-year randomized study","volume":"21","author":"Akesson","year":"1992","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2019.07.007_bib0027","doi-asserted-by":"crossref","first-page":"e74332","DOI":"10.1371\/journal.pone.0074332","article-title":"Autoantibodies to estrogen receptor alpha in systemic sclerosis (SSc) as pathogenetic determinants and markers of progression","volume":"8","author":"Giovannetti","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.07.007_bib0028","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/ard.50.1.41","article-title":"A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis","volume":"50","author":"Jayson","year":"1991","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.07.007_bib0029","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/rheumatology\/40.3.310","article-title":"Assessment of pituitary gonadotropin release to gonadotropin releasing hormone\/thyroid-stimulating hormone stimulation in women with systemic sclerosis","volume":"40","author":"La Montagna","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.07.007_bib0030","first-page":"21","article-title":"Dehydroepiandrosterone sulphate serum levels in systemic sclerosis","volume":"19","author":"La Montagna","year":"2001","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.07.007_bib0031","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0002-8703(98)70137-1","article-title":"Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon","volume":"136","author":"Lekakis","year":"1998","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.semarthrit.2019.07.007_bib0032","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0002-9149(98)00708-5","article-title":"Effect of long-term estrogen therapy on brachial arterial endothelium-dependent vasodilation in women with Raynaud's phenomenon secondary to systemic sclerosis","volume":"82","author":"Lekakis","year":"1998","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.07.007_bib0033","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/rheumatology\/keu432","article-title":"Androgens in post-menopausal patients with systemic sclerosis","volume":"54","author":"Perkovic","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2019.07.007_bib0034","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1749-6632.2002.tb04221.x","article-title":"Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis","volume":"966","author":"Scorza","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.07.007_bib0035","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/ar4587","article-title":"Effect of menopause on the modified Rodnan skin score in systemic sclerosis","volume":"16","author":"Vinet","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.semarthrit.2019.07.007_bib0036","first-page":"1613","article-title":"Klinefelter's syndrome and scleroderma","volume":"16","author":"De Keyser","year":"1989","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2019.07.007_bib0037","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00296-009-1129-7","article-title":"What is the relationship between disease activity, severity and damage in a large Canadian systemic sclerosis cohort? Results from the Canadian scleroderma research group (CSRG)","volume":"30","author":"Fan","year":"2010","journal-title":"Rheumatol Int"},{"issue":"Suppl 113(4)","key":"10.1016\/j.semarthrit.2019.07.007_bib0038","first-page":"50","article-title":"Development of systemic sclerosis in transgender females: a case series and review of the literature","volume":"36","author":"Campochiaro","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2019.07.007_bib0039","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/rheumatology\/key166","article-title":"2-Methoxyestradiol inhibits hypoxia-induced scleroderma fibroblast collagen synthesis by phosphatidylinositol 3-kinase\/Akt\/mTOR signalling","volume":"57","author":"Zhou","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.07.007_bib0040","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/03009740600844498","article-title":"Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement","volume":"35","author":"Beretta","year":"2006","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2019.07.007_bib0041","first-page":"2235","article-title":"Lower adrenocortical and adrenomedullary responses to hypoglycemia in premenopausal women with systemic sclerosis","volume":"33","author":"Imrich","year":"2006","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.07.007_bib0042","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02231564","article-title":"Systemic sclerosis following anti-androgenic treatment for prostatic adenocarcinoma","volume":"12","author":"Giordano","year":"1993","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.07.007_bib0043","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.0954-6820.1974.tb01058.x","article-title":"Treatment of progressive systemic sclerosis with a synthetic weak estrogen: cyclofenil (Sexovid). Report of a case","volume":"196","author":"Herbai","year":"1974","journal-title":"Acta Med Scand."},{"issue":"3","key":"10.1016\/j.semarthrit.2019.07.007_bib0044","first-page":"605","article-title":"Male hypogonadism and scleroderma","volume":"12","author":"Nowlin","year":"1985","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.07.007_bib0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.0954-6820.1981.tb09842.x","article-title":"Cyclofenil versus placebo in progressive systemic sclerosis. A one-year double-blind crossover study of 27 patients","volume":"210","author":"Blom-Bulow","year":"1981","journal-title":"Acta Med Scand"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.07.007_bib0046","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/rheumatology\/22.4.218","article-title":"Cyclofenil treatment of scleroderma \u2013 a controlled study","volume":"22","author":"Gibson","year":"1983","journal-title":"Br J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.07.007_bib0047","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF02208039","article-title":"Klinefelter's syndrome associated with progressive systemic sclerosis: report of a case and review of the literature","volume":"10","author":"Kobayashi","year":"1991","journal-title":"Clin Rheumatol"},{"issue":"683","key":"10.1016\/j.semarthrit.2019.07.007_bib0048","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/pgmj.58.683.575","article-title":"Klinefelter's syndrome associated with systemic sclerosis","volume":"58","author":"O'Donoghue","year":"1982","journal-title":"Postgrad Med J"},{"issue":"5","key":"10.1016\/j.semarthrit.2019.07.007_bib0049","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00376615","article-title":"Circulating androgens in male patients suffering from systemic scleroderma","volume":"283","author":"Jemec","year":"1991","journal-title":"Arch Dermatol Res"},{"issue":"7","key":"10.1016\/j.semarthrit.2019.07.007_bib0050","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00296-007-0501-8","article-title":"Chromosome 5 inversion in two siblings, one with Klinefelter syndrome and systemic sclerosis, the other with rheumatoid arthritis","volume":"28","author":"Bargagli","year":"2008","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.07.007_bib0051","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1196\/annals.1351.023","article-title":"Androgen and prolactin (Prl) levels in systemic sclerosis (SSc): relationship to disease severity","volume":"1069","author":"Mirone","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.semarthrit.2019.07.007_bib0052","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/ard.2008.097378","article-title":"Endothelin and sex hormones modulate the fibronectin synthesis by cultured human skin scleroderma fibroblasts","volume":"68","author":"Soldano","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.07.007_bib0053","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.2009.05296.x","article-title":"Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts","volume":"1193","author":"Soldano","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.07.007_bib0054","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13075-019-1870-6","article-title":"Estradiol levels are elevated in older men with diffuse cutaneous SSc and are associated with decreased survival","volume":"21","author":"Baker Frost","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.07.007_bib0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.imlet.2010.07.001","article-title":"Sex hormones and autoimmunity","volume":"133","author":"Gonzalez","year":"2010","journal-title":"Immunol Lett"},{"issue":"6","key":"10.1016\/j.semarthrit.2019.07.007_bib0056","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/00128071-200304060-00001","article-title":"Skin aging and menopause: implications for treatment","volume":"4","author":"Raine-Fenning","year":"2003","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.07.007_bib0057","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jdermsci.2014.10.007","article-title":"2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation","volume":"77","author":"Zhu","year":"2015","journal-title":"J Dermatol Sci"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.07.007_bib0058","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1164\/rccm.201201-0058PP","article-title":"Estrogen paradox in pulmonary hypertension current controversies and future perspectives","volume":"186","author":"Umar","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.07.007_bib0059","doi-asserted-by":"crossref","first-page":"208","DOI":"10.7326\/0003-4819-129-3-199808010-00009","article-title":"The association of estrogen replacement therapy and the raynaud phenomenon in postmenopausal women","volume":"129","author":"Fraenkel","year":"1998","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2019.07.007_bib0060","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi consensus study from EULAR scleroderma trials and research group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2019.07.007_bib0061","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1515\/afpuc-2016-0017","article-title":"Autoimmune rheumatic diseases and Klinefelter syndrome autoimunitne reumaticke choroby a klinefelterov syndrom","volume":"63","author":"Lazurova","year":"2016","journal-title":"Eur Pharm J"},{"key":"10.1016\/j.semarthrit.2019.07.007_bib0062","article-title":"Androgen deprivation therapy for prostate cancer and the risk of autoimmune diseases","author":"Liu","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2019.07.007_bib0063","first-page":"99","article-title":"Open label trial of tamoxifen in scleroderma","volume":"21","author":"Thomas-Golbanov","year":"2003","journal-title":"Clin Exp Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017219302987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017219302987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:00:16Z","timestamp":1758733216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017219302987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0049017219302987"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2019.07.007","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex hormones and sex hormone-targeting therapies in systemic sclerosis: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2019.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}